Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Open | $2.800 |
Close | $2.720 |
Volume / Avg. | 32.552K / 1.444M |
Day Range | 2.650 - 2.820 |
52 Wk Range | 2.350 - 44.800 |
Market Cap | $4.521M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 1.75% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and NexImmune (NASDAQ:NEXI).
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on Thursday, April 18, 2024. The analyst firm set a price target for 40.00 expecting BPTH to rise to within 12 months (a possible 1284.90% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $2.8883 last updated May 10, 2024 at 9:06 AM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.